MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.
about
Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci.Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique.Tolerance of Haemophilus influenzae to beta-lactam antibioticsAntistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus.Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevanceSerum bactericidal rate as measure of antibiotic interactionsRelationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype.Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci.Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae.Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycinSerum bactericidal testMRSA decolonization failure-are biofilms the missing link?Standardization of the serum bactericidal test and its relationship to levels of antimicrobial agents.Technical aspects and clinical correlations of the serum bactericidal test.Problems in in vitro determination of antibiotic tolerance in clinical isolates.Oxacillin, cephalothin, and vancomycin tube macrodilution MBC result reproducibility and equivalence to MIC results for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates.Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditisLack of reproducibility of macrodilution MBCs for Staphylococcus aureus.Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.Violacein antimicrobial activity on Staphylococcus epidermidis and synergistic effect on commercially-available antibiotics.Influence of technical factor variations on serum inhibition and bactericidal titers.Statins: antimicrobial resistance breakers or makers?Antimicrobial Effects of Violacein against Planktonic Cells and Biofilms of Staphylococcus aureus.Comparative activity of meropenem (SM-7338) against major respiratory pathogens and amikacin-resistant nosocomial isolates.In vitro antibacterial and time-kill evaluation of the Erythrina caffra Thunb. extract against bacteria associated with diarrhoea.
P2860
Q33741953-90B38EEE-2C94-48F0-B641-3B7E5920F0EAQ33960932-52B4C4D2-A20F-4F30-B599-4F0D4FE6000FQ34693259-D7C5F531-12BF-4B9B-98A6-D6B9C01454C0Q35275354-2D1BA2A5-1E12-4FAD-AFD1-2169F85DF275Q35290985-81A9E577-1DCD-485E-9EEB-28C5C382E808Q35474824-54F4FBF4-54CC-4F65-B3D7-B14FCA89C137Q35539637-B04F6C2C-D386-4331-8C61-A9663785A31DQ35541416-DC1C05E3-080F-49DE-B45A-FDA0E5A6601DQ35565639-E85B7C59-67E8-4CB4-A8E0-54163259F686Q35566072-92DB52A1-2E03-49B5-B34E-5842E2B34FEEQ35574121-4F91FA89-8132-472D-B206-7CACB1857C02Q35650617-519C232B-FF9C-4EAD-9D2E-1811B5A773EBQ35653907-4E528D3E-6C4E-4F13-AB64-F07EE7966077Q36632471-203F4C6D-1A47-47A8-BF67-0E5660BA2211Q38865746-D5C7C170-F189-4752-8EC2-D463CA34D8DFQ39731812-BA2437D1-F9AE-49F9-BE63-198591E95345Q39731823-7BD26F47-2893-41BA-B71C-379A35DF4102Q39753950-7351E6AB-4F1B-4EEE-B77D-666CD0221EEFQ39817823-7120995E-9350-49A2-92E6-A76BD333555FQ39828881-710D3BBA-15A3-4517-B1B5-42BF61BC5354Q39833604-91C7936D-CD50-41E6-BAC5-6CEA62C1A3EFQ39849397-2E412AFA-F828-45E0-BB2A-15D584FC0F4EQ39850768-1BE8C637-5275-4B2A-B69C-DBC03781ED73Q40119383-77883207-C037-4E40-B4AE-555960B362A7Q40206015-FFCCCBFF-01C4-4D05-B2BA-C7044F77E09CQ47140385-DA3F8C31-CF0F-4F02-A040-82D574C2DF46Q48293531-BBD0F9C2-B0A9-4DA3-BEA9-3231FB2E80AEQ54685330-037D5F8B-5F5B-440F-B050-4712A14E7A66Q55651790-D24BACED-B880-469D-B564-66EE34A8EBCD
P2860
MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
MBCs for Staphylococcus aureus ...... and microdilution techniques.
@en
type
label
MBCs for Staphylococcus aureus ...... and microdilution techniques.
@en
prefLabel
MBCs for Staphylococcus aureus ...... and microdilution techniques.
@en
P2093
P2860
P356
P1476
MBCs for Staphylococcus aureus ...... and microdilution techniques.
@en
P2093
Gerding DN
Peterson LR
Shanholtzer CJ
P2860
P304
P356
10.1128/AAC.26.2.214
P407
P577
1984-08-01T00:00:00Z